Depression, Bipolar Clinical Trial
Official title:
A Double-Blind, Placebo-Controlled Trial of Combined Cytidine- and Creatine-containing Drug and Dietary Supplement in the Treatment of the Bipolar Depression
This research is aimed to investigate the efficacy and safety of the creatine and cytidine augmentation in treating bipolar depression and to evaluate changes in relevant brain biochemical metabolism using proton and phosphorous magnetic resonance spectroscopy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04469322 -
Pharmacogenetic Implementation Trial in Veterans With Treatment Refractory Depression
|
N/A | |
| Not yet recruiting |
NCT05958940 -
BioClock: Bright Light Therapy for Depressive Disorders
|
N/A | |
| Recruiting |
NCT02919280 -
Dallas 2K: A Natural History Study of Depression
|
||
| Completed |
NCT00060489 -
Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
|
Phase 3 | |
| Recruiting |
NCT05767073 -
LIVES: Personalized Lifestyle Intervention for Patients With Depression
|
N/A | |
| Completed |
NCT04121091 -
Pramipexole to Target "Anhedonic Depression"
|
Phase 2 | |
| Recruiting |
NCT04057378 -
Optimal Electrical Stimulus During Electroconvulsive Therapy
|
Phase 4 | |
| Completed |
NCT03287037 -
The Effects of tDCS on Depressive Symptoms,Neurocognitive Function and HRV in Unipolar Depression and Bipolar Depression
|
N/A | |
| Completed |
NCT00483548 -
Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
|
Phase 3 | |
| Not yet recruiting |
NCT05568823 -
Biomarkers of ANTidepressant RESponse and Development Risk of Bipolar Disorder
|
N/A | |
| Completed |
NCT00191399 -
Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response
|
Phase 4 | |
| Recruiting |
NCT05436613 -
Transcranial Direct Current Stimulation Therapy for Bipolar Depression
|
N/A | |
| Completed |
NCT03538275 -
Chronobiology and Depression: Circadian Analytics as a Biomarker for Depressive Subtypes
|
||
| Recruiting |
NCT04846010 -
Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02778256 -
Study of the Effectiveness of Vestibular Stimulation Treatment in the Depressive Phase of Bipolar Disorder
|
N/A | |
| Active, not recruiting |
NCT04643210 -
Management of my Bipolarity Intervention in Bipolar Disorder Patients
|
N/A | |
| Completed |
NCT01396447 -
Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression
|
Phase 2 | |
| Enrolling by invitation |
NCT02827045 -
Study of a Vestibular Biomarker of Phase in Bipolar Disorder
|
||
| Completed |
NCT01898429 -
Deep Brain Stimulation (DBS) for Treatment-Resistant Depression (TRD)
|
N/A | |
| Completed |
NCT01303601 -
Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression
|
Phase 4 |